Easywell Biomedicals, Inc. (TPEX:1799)
Taiwan · Delayed Price · Currency is TWD 33.50
+0.30 (0.90%)
May 29, 2026, 12:53 PM CST
Easywell Biomedicals Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -52.13 | -73.14 | -97.47 | -144.82 | -161 | -150.39 |
Depreciation & Amortization | 96.42 | 91.02 | 79.78 | 65.13 | 66.55 | 70.78 |
Other Amortization | 0.11 | 0.11 | 0.1 | 0.02 | - | 0.1 |
Loss (Gain) From Sale of Assets | -0.01 | -0.18 | -0.03 | - | - | -0.24 |
Loss (Gain) From Sale of Investments | -6.21 | - | - | - | - | - |
Stock-Based Compensation | 3.05 | 3.66 | 12.44 | 16.96 | - | - |
Provision & Write-off of Bad Debts | -4.86 | -2.65 | 4.98 | - | - | - |
Other Operating Activities | -1.04 | -11.61 | 9.24 | -25.14 | -7.46 | -37.23 |
Change in Accounts Receivable | -19.79 | 4.43 | 23.38 | -47.17 | 13.08 | -5.66 |
Change in Inventory | 57.15 | 96.16 | -213.19 | -15.59 | -3.92 | 9.95 |
Change in Accounts Payable | 26.58 | -36.01 | 35.53 | 7.17 | 1.78 | 0.08 |
Change in Unearned Revenue | 27.04 | 34.94 | -8.54 | 5.7 | 20.56 | -4.08 |
Change in Other Net Operating Assets | 34.21 | 38.31 | 14.9 | -13.72 | 1.9 | 3.39 |
Operating Cash Flow | 160.52 | 124.78 | -159.04 | -151.45 | -53.5 | -128.31 |
Capital Expenditures | -12.31 | -15.41 | -12.49 | -17.73 | -7.49 | -7.71 |
Sale of Property, Plant & Equipment | 0.01 | 0.18 | 0.08 | - | - | 0.24 |
Sale (Purchase) of Intangibles | - | - | -0.26 | -0.82 | - | - |
Investment in Securities | -92.3 | -9.84 | -35.15 | 106.38 | 80.14 | -175.07 |
Other Investing Activities | -0.06 | 0.03 | 0.17 | -0.37 | 0.01 | - |
Investing Cash Flow | -104.66 | -25.04 | -47.66 | 87.46 | 72.66 | -182.54 |
Short-Term Debt Issued | - | 86.58 | 200.1 | 43.93 | - | - |
Total Debt Issued | 29.56 | 86.58 | 200.1 | 43.93 | - | - |
Short-Term Debt Repaid | - | -194.4 | -44.56 | - | - | - |
Long-Term Debt Repaid | - | -17.16 | -14.19 | -15.47 | -10.55 | -9.45 |
Total Debt Repaid | -158.06 | -211.56 | -58.75 | -15.47 | -10.55 | -9.45 |
Net Debt Issued (Repaid) | -128.5 | -124.98 | 141.34 | 28.46 | -10.55 | -9.45 |
Issuance of Common Stock | - | 169.17 | 171.84 | 15 | - | 329.76 |
Repurchase of Common Stock | - | - | -0.75 | - | - | - |
Other Financing Activities | 5.17 | -186.89 | -49.37 | 134.39 | - | - |
Financing Cash Flow | -123.32 | -142.7 | 263.06 | 177.84 | -10.55 | 320.31 |
Foreign Exchange Rate Adjustments | 0.81 | -1.64 | 6.41 | -9.98 | -2.61 | -1.33 |
Net Cash Flow | -66.66 | -44.6 | 62.76 | 103.88 | 6 | 8.14 |
Free Cash Flow | 148.21 | 109.37 | -171.53 | -169.17 | -60.99 | -136.02 |
Free Cash Flow Margin | 21.71% | 18.31% | -31.74% | -62.28% | -34.09% | -68.95% |
Free Cash Flow Per Share | 1.19 | 0.88 | -1.43 | -1.48 | -0.53 | -1.28 |
Cash Interest Paid | 22.45 | 22.45 | 21.34 | 19.03 | 17.25 | 16.08 |
Cash Income Tax Paid | 0.25 | 0.25 | 0.42 | 0.42 | 0.19 | 0.84 |
Levered Free Cash Flow | 131.36 | 89.05 | -42.68 | -117.85 | -28.28 | -79.6 |
Unlevered Free Cash Flow | 144.21 | 103.1 | -29.46 | -105.81 | -17.5 | -69.55 |
Change in Working Capital | 125.19 | 117.56 | -168.08 | -63.6 | 48.41 | -11.32 |